LRMR
Price
$6.69
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
56 days until earnings call
SVRA
Price
$4.32
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
51 days until earnings call
Ad is loading...

LRMR vs SVRA

Header iconLRMR vs SVRA Comparison
Open Charts LRMR vs SVRABanner chart's image
Larimar Therapeutics
Price$6.69
Change-$0.00 (-0.00%)
Volume$1M
CapitalizationN/A
Savara
Price$4.32
Change-$0.00 (-0.00%)
Volume$1.46M
CapitalizationN/A
View a ticker or compare two or three
LRMR vs SVRA Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
LRMR vs. SVRA commentary
Sep 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and SVRA is a Hold.

COMPARISON
Comparison
Sep 18, 2024
Stock price -- (LRMR: $6.69 vs. SVRA: $4.32)
Brand notoriety: LRMR and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 233% vs. SVRA: 154%
Market capitalization -- LRMR: $426.87M vs. SVRA: $729.18M
LRMR [@Biotechnology] is valued at $426.87M. SVRA’s [@Biotechnology] market capitalization is $729.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.74B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 2 TA indicator(s) are bullish while SVRA’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 2 bullish, 6 bearish.
  • SVRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а -11.27% price change this week, while SVRA (@Biotechnology) price change was +1.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.90%, and the average quarterly price growth was +0.15%.

Reported Earning Dates

LRMR is expected to report earnings on Nov 12, 2024.

SVRA is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($729M) has a higher market cap than LRMR($427M). LRMR YTD gains are higher at: 47.033 vs. SVRA (-8.085). LRMR has higher annual earnings (EBITDA): -65.51M vs. SVRA (-80.28M). LRMR has more cash in the bank: 226M vs. SVRA (122M). LRMR has less debt than SVRA: LRMR (5.6M) vs SVRA (26.6M). LRMR (0) and SVRA (0) have equivalent revenues.
LRMRSVRALRMR / SVRA
Capitalization427M729M59%
EBITDA-65.51M-80.28M82%
Gain YTD47.033-8.085-582%
P/E RatioN/AN/A-
Revenue00-
Total Cash226M122M185%
Total Debt5.6M26.6M21%
FUNDAMENTALS RATINGS
LRMR vs SVRA: Fundamental Ratings
LRMR
SVRA
OUTLOOK RATING
1..100
5559
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10053
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6152
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (30) in the null industry is somewhat better than the same rating for SVRA (77) in the Biotechnology industry. This means that LRMR’s stock grew somewhat faster than SVRA’s over the last 12 months.

SVRA's Profit vs Risk Rating (53) in the Biotechnology industry is somewhat better than the same rating for LRMR (100) in the null industry. This means that SVRA’s stock grew somewhat faster than LRMR’s over the last 12 months.

SVRA's SMR Rating (98) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that SVRA’s stock grew similarly to LRMR’s over the last 12 months.

SVRA's Price Growth Rating (52) in the Biotechnology industry is in the same range as LRMR (61) in the null industry. This means that SVRA’s stock grew similarly to LRMR’s over the last 12 months.

SVRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that SVRA’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRSVRA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SOAUX20.660.18
+0.88%
Spirit of America Utilities A
RDCCX8.800.07
+0.80%
Columbia Disciplined Value C
QICNX14.260.10
+0.71%
AQR International Multi-Style N
DIHRX13.540.08
+0.59%
DFA Intl Hi Relatv Profitability Instl
PRJZX47.52N/A
N/A
PGIM Jennison Global Opportunities Z

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-7.08%
SVRA - LRMR
44%
Loosely correlated
+2.86%
ALLO - LRMR
40%
Loosely correlated
-6.76%
SNDX - LRMR
39%
Loosely correlated
-4.81%
HRTX - LRMR
39%
Loosely correlated
-2.14%
ABUS - LRMR
38%
Loosely correlated
-4.70%
More